Febgout 40mg Tablet contains Febuxostat, a xanthine oxidase inhibitor used primarily to manage hyperuricemia in patients with gout. By selectively inhibiting the enzyme xanthine oxidase, Febuxostat reduces the production of uric acid, thereby helping to prevent gout attacks and the formation of urate crystals in joints and tissues. This medication is typically prescribed for patients who have not responded well to other urate-lowering therapies or who are intolerant to allopurinol. Febgout 40mg is taken orally, usually once daily, with or without food, and the dosage may be adjusted based on serum uric acid levels and clinical response. It is important to maintain adequate hydration while on this medication to reduce the risk of kidney stones. Common side effects may include nausea, joint pain, rash, and liver enzyme abnormalities, so regular monitoring of liver function tests is recommended during treatment. Febgout should be used cautiously in patients with cardiovascular disease or liver impairment. Patients are advised to inform their healthcare provider about any other medications they are taking to avoid potential drug interactions. Overall, Febgout 40mg Tablet is an effective option for long-term management of gout by controlling uric acid levels and reducing the frequency of gout flares.